ZYOMYX
closedZyomyx develops and commercializes diagnostic platforms, including a point-of-care test for HIV/AIDS.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD88—132m (Dealroom.co estimates Jul 2013.)
Fremont California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $560k | Seed | |
$12.0m | Series B | ||
N/A | $14.2m | Late VC | |
N/A | $7.5m | Grant | |
Total Funding | AUD52.9m |